Engelbert Coster Tjeenk Willink

Biography

Born October 7, 1960 Since July 4, 2017 Chairman of the Executive Board/CEO at STADA Arzneimittel AG and also responsible for Marketing and Operations (under contract until 12/31/2017) Since 2013 (current roles) Lipid Therapeutics GmbH (Chairman of the Advisory Board) BiosanaPharma BV (Chairman of the Advisory Board) Allecra Therapeutics GmbH (Chairman of the Advisory Board) JoyDew LLC, Filag Schweiz AG (Non-Executive Board Member) Since 2013 (previous roles) GHO Capital Partners (Investing Chair) Black Bear Carbon NV (Advisor) Feingold Technologies GmbH (Non-Executive Board Member) Skura Corporation (Advisory Board Member) Novartis, KMS Group Management GmbH (Strategy Advisor) MedaPharma (Mentoring Executive Board Member) 1994 - 2012 Boehringer Ingelheim GmbH Jan 2009 - Dec 2012: Member of the Board of Managing Directors, Corporate Board Division Marketing & Sales Jan 2005 - Dec 2008: Country Manager, Mexico Jan 2002 - Dec 2004: Head of Corporate Division Marketing PM Jan 1999 - Dec 2001: Head Marketing & Sales PM, Canada Jan 1998 - Dec 1998: Regional Business Manager North America Jan 1997 - Dec 1997: Product Manager Mobec® Jul 1995 - Dec 1996: Head Corporate Health Economics Apr 1994 - Jun 1995: Medical Director, The Netherlands 1991 - 1994 Pharma Bio-Research BV Jan 1992 - March 1994: Manager Operations May 1989 - Dec 1991: Head of Clinical Research Center 1988 - 1989 Gist-brocades BV – International Clinical Monitor, Dermatology 1978 - 1987 Studies at the Erasmus University Rotterdam School of Medicine and University of Florida, Gainesville

Research Interest

Clinical Research ,Lipid Therapeutics,Molecular Biology